Healx
PrivateLast Round
Series C
Aug 1, 2024
Total Funding Raised
$114.9M
Company Overview
Healx operates in Healthcare & Life Sciences and is based in Cambridge. Its latest recorded funding round was a Series C round in August 2024.
Healx is a biotechnology company that utilizes artificial intelligence-driven drug discovery technology to develop treatments for rare diseases.
Sector
Healthcare & Life Sciences
Verticals
Drug Discovery, Biotechnology, Medical AI, Clinical Trials
Business Model
B2B
Customer Profile
Services & Consulting, Revenue Share
AI Layer
Application
Historical Pricing
Historical view of private secondary pricing and transaction trends.
Healx Comparables
Compare Healx with similar companies based on industry and business-model similarity.
| Company | Similarity | Market Cap |
|---|---|---|
| SOM Biotech | 84% | |
| Delta4 | 82% | |
| Purposeful | 82% |
For institutional investors. Book with your work email.
Healx Funding Rounds
Historical fundraising activity
| Round | Date | Amount Raised | Valuation | Investors | Sources |
|---|---|---|---|---|---|
| Series C | Aug 1, 2024 | ||||
| Series B | Oct 16, 2019 | ||||
| Series A | Jul 26, 2018 | ||||
| Seed | Oct 4, 2016 |
For institutional investors. Book with your work email.
Key People
Founding team and executive leadership
For institutional investors. Book with your work email.
Healx Investors
Notable investors and investment history
| Investor | Rounds |
|---|---|
| Amadeus Capital Partners | Series A, Series B, Seed |
| o2h ventures | Series C |
| Global Brain Corporation | Series C, Series B |
| Meltwind Advisory | Seed, Series A, Series B |
| Intel Capital | Series B |
| b2venture | Series C, Series B |
| VU Venture Partners | Series C |
For institutional investors. Book with your work email.
Market signals
Structured signals derived from secondary market and firmographic data.
- Sep 1, 2025
Partnered with Vuja De Sciences to focus on oncology.
- Jul 1, 2025
Drug candidates have entered clinical trials, indicating a clinical-stage development.
For institutional investors. Book with your work email.
Healx Filings
Explore SEC and related filing metadata, where available.
| Type | Date | Amount Offered | Amount Sold | Filing | Pages | Download |
|---|
Filing documents are not displayed on this public page. Request access to learn about available coverage.
Book a demoFor institutional investors. Book with your work email.
Frequently Asked Questions
Common questions about Healx's valuation, stock price, and market status.
Is Healx a public or private company?
Healx is a private company.
What is the current stock price of Healx?
Healx is a private company, so its shares have no public market price. Caplight tracks Healx's secondary market activity and provides MarketPrice™ estimates of its share price to Caplight users.
How much is Healx worth (valuation)?
Valuation information for Healx is not publicly available.
Can I buy Healx stock?
Healx shares may be available on secondary markets subject to transfer restrictions. Caplight facilitates secondary market transactions for accredited investors.
When was Healx's last funding round?
Healx's most recent funding round was Series C on August 1, 2024.
Who are the main investors in Healx?
Key investors in Healx include Amadeus Capital Partners, Meltwind Advisory, Atomico, Balderton Capital, R42 Group.
Will Healx IPO soon?
No public IPO plans have been announced for Healx.
How can I track Healx secondary market activity?
Caplight tracks bids, offers, and trades in Healx's shares on secondary markets.